Blue Blends (I) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
Awaiting price reaction for this filing.
The board, at its April 17, 2026 meeting, approved unaudited standalone and consolidated results for Q1, Q2 and Q3 FY2025-26, filed together due to delays from the insolvency resolution process. For Q2 FY26 (quarter ended Sept 30, 2025), standalone revenue from operations jumped to Rs 528.10 lakhs from Rs 99.18 lakhs in Q1 FY26 and Rs 118.07 lakhs in Q2 FY25, with a standalone profit before tax of Rs 42.05 lakhs, a sharp turnaround from the Rs 162.50 lakh loss in Q1 FY26. However, the half-year (H1 FY26) still showed a cumulative standalone loss of Rs 120.45 lakhs and a negative operating cash flow of Rs 190.83 lakhs. The company was admitted to CIRP in December 2021, the NCLT approved a resolution plan on December 6, 2024, and NCLAT issued a clarification order on February 18, 2026. Under the approved plan, all existing equity and preference shares will be cancelled with no payment to current shareholders, and the Successful Resolution Applicant (SRA) will subscribe to fresh equity, followed by a re-listing process. The statutory auditor gave a clean limited review but drew attention (emphasis of matter) to the share cancellation and re-listing notes.
Existing shareholders stand to lose their entire investment as their shares will be extinguished without any payout under the NCLT-approved resolution plan; the stock will eventually be re-listed under a new capital structure. Operationally, the company remains weak with cumulative H1 losses and negative operating cash flow, so the Q2 profit appears more like a one-off than a sustainable recovery.